Given the better prognosis of the high SPN-R signature group compared with that of the low SPN-R signature group in patients with ACC, the zR-like structure might exert a negative effect on adrenocortical cell proliferation or even an anti-adrenocortical tumorigenic effect. This evidence concerns the gene STRBP and adrenal cortex carcinoma.